Stay updated on Amivantamab SC in Advanced Solid Malignancies Clinical Trial

Sign up to get notified when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Administrative updates to the study record dates and metadata were added. No changes to core study details, eligibility criteria, or outcomes are evident.
    Difference
    0.2%
    Check dated 2026-02-19T04:49:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2; there are no changes to core study content such as trial details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:25:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. No user-visible changes to study content or page layout.
    Difference
    0.1%
    Check dated 2026-02-04T22:44:31.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Glossary UI is now displayed, and a new label 'Last Update Submitted that Met QC Criteria' appears, along with a revision note 'Revision: v3.4.0'. The prior 'Last Update Submitted that met QC Criteria' label and the 'No FEAR Act data' entry were removed or reformatted.
    Difference
    0.2%
    Check dated 2026-01-28T21:41:22.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The label 'Last Update Posted' has changed to 'Last Update Posted (Estimated)' in the Study Record Dates. This is a minor display change that does not affect the study data or outcomes — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T08:59:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added MedlinePlus related topic 'Neoplasms' and expanded eligibility language to cover Part 1 and Part 2 criteria for histologically confirmed solid malignancies with SC administration arms Ami-LC-MD, Ami-LC, Ami-HC, and Ami-HC-CF. Removed Part 3 arms that included Lazertinib combinations with Amivantamab.
    Difference
    2%
    Check dated 2026-01-14T04:46:14.000Z thumbnail image

Stay in the know with updates to Amivantamab SC in Advanced Solid Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.